Drugs

Mark Lewis: From the first day of fellowship I was taught to “respect oxaliplatin”

Mark Lewis/netrf.org

Aug 31, 2024, 17:49

Mark Lewis: From the first day of fellowship I was taught to “respect oxaliplatin”

Mark Lewis reshared a post on X by Erman Akkus, Medical Oncology Fellow at Ankara University, adding:

“From my very first day of fellowship I was taught to “respect oxaliplatin” That drug is nothing to trifle with, especially concerning the risk of irreversible neuropathy Kudos to the investigators for enhancing our understanding of GI and geriatric oncology.”

Quoting Erman Akkus’s post:

“FOLFOX/Xelox + beva vs. 5FU/cape +beva in first line treatment of metastatic CRC in older patients at Journal of Clinical Oncology.

Median age 80 and 79

No difference in PFS, 10 vs 9.4 mo.
No difference in OS, 19.7 vs 21.3 mo.
grade ≥3 AEs 69% vs. 52%.

~65% left sided and ~36% RAS WT.”

Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018)

Authors: Atsuo Takashima, Tetsuya Hamaguchi, Junki Mizusawa, Fumio Nagashima, Masahiko Ando, Hitoshi Ojima, Tadamichi Denda, Jun Watanabe, Katsunori Shinozaki, Hideo Baba, Masako Asayama, Seiji Hasegawa, Toshiki Masuishi, Ken Nakata, Shunsuke Tsukamoto, Hiroshi Katayama, Kenichi Nakamura, Haruhiko Fukuda, Yukihide Kanemitsu, and Yasuhiro Shimada.

Mark Lewis: From the first day of fellowship I was taught to “respect oxaliplatin"

Source: Mark Lewis/X and Erman Akkus/X

Mark A. Lewis is the Director of Gastrointestinal Oncology at Intermountain Healthcare in Utah, the Co-Chair of adolescent and young adult (AYA) oncology in the SWOG cooperative group, and the Vice President of American Multiple Endocrine Neoplasia Support. Dr. Lewis is also a well-known patient advocate and social media influencer. His interests are neuroendocrine tumors and cancer syndromes.

Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.

Ankara University Atsuo Takashima cancer Erman Akkus fellowship Geriatric Oncology Haruhiko Fukuda Junki Mizusawa Mark Lewis Metastatic colorectal cancer neuropathy OncoDaily Oncology oxaliplatin respect oxaliplatin Tetsuya Hamaguchi Yasuhiro Shimada Yukihide Kanemitsu

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage